Ferrlecit Articles
Stock Commentary - New York week to Feb 23, 2009
2 March 2009
Watson's 1st-qtr 2008 net income jumps 60%
12 May 2008
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
Baxter outlines growth strategy
25 March 2002
Ferrlecit appro a fillip for Schein after INFeD woes
22 February 1999
Schein Acquires Rights To R&D Labs' Ferrlecita
30 April 1998
Showing 1-6 of 6 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
